Ivabradine in Stable Coronary Artery Disease REPLY

被引：16
作者：
Fox, Kim [1 ]
Ford, Ian [2 ]
Ferrari, Roberto [3 ]
机构：
[1] Univ London Imperial Coll Sci Technol & Med, London, England
[2] Univ Glasgow, Glasgow, Lanark, Scotland
[3] Univ Hosp Ferrara, Ferrara, Italy
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2014年 / 371卷 / 25期
关键词：
D O I：
10.1056/NEJMc1413158
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2435 / 2435
页数：1
相关论文
共 4 条
[1]   Ivabradine in Stable Coronary Artery Disease without Clinical Heart Failure [J].
Fox, Kim ;
Ford, Ian ;
Steg, Philippe Gabriel ;
Tardif, Jean-Claude ;
Tendera, Michal ;
Ferrari, Roberto .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (12) :1091-1099
[2]   Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials [J].
Martin, Ruairidh I. R. ;
Pogoryelova, Oksana ;
Koref, Mauro Santibanez ;
Bourke, John P. ;
Teare, M. Dawn ;
Keavney, Bernard D. .
HEART, 2014, 100 (19) :1506-1510
[3]   Ivabradine, Coronary Heart Disease, and Heart Failure: Time for Reappraisal [J].
Stulc, Tomas ;
Ceska, Richard .
CURRENT ATHEROSCLEROSIS REPORTS, 2014, 16 (12) :1-4
[4]   Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study [J].
Swedberg, Karl ;
Komajda, Michel ;
Boehm, Michael ;
Borer, Jeffrey S. ;
Ford, Ian ;
Dubost-Brama, Ariane ;
Lerebours, Guy ;
Tavazzi, Luigi .
LANCET, 2010, 376 (9744) :875-885
1